Your Trusted Diagnostic Partner
in Rare Disease and Reproductive Genetic Care


80000+
Genetic Tests Reports
500+
Project Executed for Global Genomics Majors
Presence in 20+ countries

Comprehensive Genomics for all stages of Life

From preconception carrier screening to adult genome sequencing. We offer a suite of accessible and high-quality solutions to empower individuals with informed decision-making, facilitate efficient diagnosis, and promote a healthier life for all.

Reproductive Health Test Portfolio

Carrier Screening
Identifies couples with Autosomal Recessive/ X-linked disease-causing mutations in ~2000 genes to asses risk in pregnancy.
Infertility Screening panel
The Infertility Panel conducts a comprehensive assessment and diagnostics for couples struggling with infertility
Preimplantation Genetic Testing (PGT-A)
PGT-A is a NGS-based embryo screening test to accurately screen chromosomal aneuploidies and abnormalities in embryos created via IVF
MaatriSeq NIPS
A sensitive non-invasive prenatal screening test for common chromosomal aneuploidies in pregnancy by evaluating fetal cDNA from maternal blood
AneuXpress: QF-PCR
Quantitative fluorescent PCR test for rapid detection of common fetal aneuploidies
CNSeq
CNSeq is a revolutionary analysis tool that marks a substantial leap forward in Chromosomal Analysis compared to traditional cytogenetic methods
CNSeqHD
CNSeqHD is a higher resolution chromosomal analysis technique enabling a more comprehensive grasp of structural variations in the genome
ExomePlus
ExomePlus is comprehensive whole exome sequencing to identify medically relevant DNA changes in a patient

Carrier Screening

Carrier screening is a critical component of preconception and prenatal care that helps to identify individuals who might be carriers for Autosomal recessive and X-linked genetic disorder and empower couples with well-informed reproductive decisions. Choose Strand carrier Screening for:

  • Additional analyses for challenging genes such as SMN1, CYP21A2, DMD and CFTR
  • Annual case level reanalysis and variant reclassification

Infertility Screening Panel

The infertility Panel conducts a comprehensive assessment and diagnostics for couples struggling to conceive after a year of attempts. This targeted screening enables to:

  • Identify potential causes of infertility in either or both partners, empowering clinicians to effectively rule out underlying issues.
  • Guide couples towards personalized treatment options tailored to their unique situation

Empowering clinicians to diagnose patients with infertility causes such as:

PGT-A is an NGS-based technology to accurately screen for chromosomal aneuploidies and large fragments of copy number abnormalities in embryos created via IVF. This helps you select the embryo with the highest potential for a healthy, ongoing pregnancy by identifying those with the correct number of chromosomes.

PGT-A enables you to choose the healthiest embryo for transfer, increasing your chances of achieving a successful pregnancy and reduces the risks associated with multiples pregnancies.

MaatriSeq NIPS

MaatriSeq is India’s first non-Invasive Prenatal Screening (NIPS) developed on illuminas NovaSeq™ X Plus platform, tailored to and validated on the Indian population.

MaatriSeq NIPS is cell-free DNA-based screening method used to detect chromosomal abnormalities in the fetus during pregnancy. Unlike traditional biochemical methods with high false positive rates, NIPS is a more sensitive and non-invasive screening test.

Disclaimer: This test is exclusively available upon prescription by a certified clincian/clinical geneticist duly registered with PCPNDT, ensuring compliance with regulatory standards and ethical guideline.

AneuXpress: QF-PCR

AneuXpress is DNA-based Quantitative Fluorescent Polymerase Chain reaction(QF-PCR) method that has emerged as a breakthrough technique for rapid detection of common fetal aneuploidies

AneuXpress allows for the detection of even small variation in DNA, enhancing its sensitivity and specificity in the accurate identification of aneuploidies. This pivotal differentiators establish its superiority over conventional cytogenetic assessments such as karyotyping.

CNSeq

CNSeq is an advanced alternatives for chromosomal microarray analysis. This revolutionary solution, utilizing NGS technology, provides superior accuracy in detecting Copy Number Variants compared to traditional cytogenetic methods. CNSeq offers the following features:

  • Detects CNVs and aneuploidies across the genome with a resolution of 500kb for both gains and losses
  • Offers Uniform CNV calling capability
  • Capable of detecting low-level mosaicsm

CNSeqHD

CNSeqHD is a higher resolution chromosomal analysis technique meticulously crafted to offer precision and sensitivity, empowering clinicians with the ability to explore insights in details, enabling a more comprehensive grasp of structural variations in the genome with unbiased CNV calling accross the genome.

ExomePlus

ExomePlus, an unparalleled genetic solution that seamlessly intergrates chromosmal abnormalities and genetic mutations, offers a holistic understanding of genetic insights accross all protein-coding regions.

  • Detects multiple variant types with its advanced pipeline: SNPs, Small Indels, Exon level deletions & duplications
  • Utilizes bioinformatics pipelines on proprietary software of StrandNGS and StarndOmics